Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

The Relationship between Walking Speed and Step Length in Older Aged Patients.

Morio Y, Izawa KP, Omori Y, Katata H, Ishiyama D, Koyama S, Yamano Y.

Diseases. 2019 Feb 2;7(1). pii: E17. doi: 10.3390/diseases7010017.

2.

Risk of Human T-Cell Leukemia Virus Type 1 Infection in Kidney Transplantation.

Yamauchi J, Yamano Y, Yuzawa K.

N Engl J Med. 2019 Jan 17;380(3):296-298. doi: 10.1056/NEJMc1809779. No abstract available.

PMID:
30650320
4.

Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy.

Oka T, Mizuno H, Sakata M, Fujita H, Yoshino T, Yamano Y, Utsumi K, Masujima T, Utsunomiya A.

Sci Rep. 2018 Oct 8;8(1):14979. doi: 10.1038/s41598-018-33175-7.

5.

Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.

Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, Umeki K, Kubota R, Sasada K, Sobata R, Matsumoto C, Kaneko N, Tezuka K, Matsuoka S, Utsunomiya A, Koh KR, Ogata M, Ishitsuka K, Taki M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Watanabe T, Hamaguchi I.

Microbiol Immunol. 2018 Oct;62(10):673-676. doi: 10.1111/1348-0421.12644.

PMID:
30125970
6.

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity.

Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, Tsuboi Y, Takata A, Yamano Y.

Front Microbiol. 2018 Jul 25;9:1651. doi: 10.3389/fmicb.2018.01651. eCollection 2018.

7.

The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.

Kawano N, Yoshida S, Kawano S, Kuriyama T, Tahara Y, Toyofuku A, Manabe T, Doi A, Terasaka S, Yamashita K, Ueda Y, Ochiai H, Marutsuka K, Yamano Y, Shimoda K, Kikuchi I.

J Clin Exp Hematop. 2018 Sep 19;58(3):107-121. doi: 10.3960/jslrt.18011. Epub 2018 Aug 8.

8.

Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.

Hirano M, Jimbo K, Ogawa M, Ochi K, Makiyama J, Kawamata T, Yokoyama K, Tanaka T, Inamoto Y, Yamano Y, Fukuda T, Uchimaru K, Imai Y, Tojo A.

Bone Marrow Transplant. 2018 Nov;53(11):1470-1473. doi: 10.1038/s41409-018-0202-9. Epub 2018 Jul 23. No abstract available.

PMID:
30038356
9.

Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.

Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y.

N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827.

10.

Inhibitory effects of ubiquitination of synoviolin by PADI4.

Aratani S, Fujita H, Yagishita N, Yamano Y, Okubo Y, Nishioka K, Nakajima T.

Mol Med Rep. 2017 Dec;16(6):9203-9209. doi: 10.3892/mmr.2017.7764. Epub 2017 Oct 11.

PMID:
29039504
11.

Organ involvement pattern suggests subgroups within relapsing polychondritis: comment on the article by Dion et al.

Shimizu J, Yamano Y, Yudoh K, Suzuki N.

Arthritis Rheumatol. 2018 Jan;70(1):148-149. doi: 10.1002/art.40330. Epub 2017 Nov 28. No abstract available.

12.

IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.

Sawada L, Nagano Y, Hasegawa A, Kanai H, Nogami K, Ito S, Sato T, Yamano Y, Tanaka Y, Masuda T, Kannagi M.

PLoS Pathog. 2017 Sep 14;13(9):e1006597. doi: 10.1371/journal.ppat.1006597. eCollection 2017 Sep.

13.

Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K, Sasaki D, Hasegawa H, Kubota R, Sobata R, Matsumoto C, Kaneko N, Momose H, Araki K, Saito M, Nosaka K, Utsunomiya A, Koh KR, Ogata M, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Itabashi K, Yamaguchi K, Kuroda M, Watanabe T, Okuma K, Hamaguchi I.

J Clin Microbiol. 2017 Sep;55(9):2838-2849. doi: 10.1128/JCM.00659-17. Epub 2017 Jul 12.

14.

Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.

Coler-Reilly ALG, Sato T, Matsuzaki T, Nakagawa M, Niino M, Nagai M, Nakamura T, Takenouchi N, Araya N, Yagishita N, Inoue E, Yamano Y.

Neurotherapeutics. 2017 Oct;14(4):1084-1094. doi: 10.1007/s13311-017-0533-z.

15.

The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.

Kawano N, Kuriyama T, Yoshida S, Kawano S, Yamano Y, Marutsuka K, Minato S, Yamashita K, Ochiai H, Shimoda K, Ishikawa F, Kikuchi I.

J Clin Exp Hematop. 2017;56(3):135-144. doi: 10.3960/jslrt.56.135.

16.

Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.

Terada Y, Kamoi K, Ohno-Matsui K, Miyata K, Yamano C, Coler-Reilly A, Yamano Y.

Medicine (Baltimore). 2017 Feb;96(6):e6021. doi: 10.1097/MD.0000000000006021.

17.

Reducing the global burden of HTLV-1 infection: An agenda for research and action.

Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V, Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A, Gotuzzo E, Hall W, Harford J, Hermine O, Jacobson S, Macchi B, Macpherson C, Mahieux R, Matsuoka M, Murphy E, Peloponese JM, Simon V, Tagaya Y, Taylor GP, Watanabe T, Yamano Y.

Antiviral Res. 2017 Jan;137:41-48. doi: 10.1016/j.antiviral.2016.10.015. Epub 2016 Nov 11. Review.

18.

HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP.

Yamano Y, Coler-Reilly A.

J Neuroimmunol. 2017 Mar 15;304:51-55. doi: 10.1016/j.jneuroim.2016.08.012. Epub 2016 Aug 12. Review.

PMID:
27542993
19.

Developing novel treatments for HTLV-1-associated myelopathy (HAM) by investigating molecular pathomechanisms.

Araya N, Sato T, Coler-Reilly A, Yagishita N, Yamano Y.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):207-12. doi: 10.2177/jsci.39.207. Review. Japanese.

20.

Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases.

Terao C, Yoshifuji H, Yamano Y, Kojima H, Yurugi K, Miura Y, Maekawa T, Handa H, Ohmura K, Saji H, Mimori T, Matsuda F.

Rheumatology (Oxford). 2016 Sep;55(9):1686-92. doi: 10.1093/rheumatology/kew233. Epub 2016 May 30.

PMID:
27241705

Supplemental Content

Loading ...
Support Center